Page 109 - 《中国药房》2023年2期
P. 109

参考文献                                                    the task force for the diagnosis and management of atrial
          [ 1 ]  LEADER  A,GUREVICH-SHAPIRO  A,SPECTRE  G.        fibrillation of the European Society of Cardiology(ESC)
              Anticoagulant and antiplatelet treatment in cancer patients   developed  with  the  special  contribution  of  the  European
              with thrombocytopenia[J]. Thromb Res,2020,191(Suppl   Heart  Rhythm  Association(EHRA)of  the  ESC[J].  Eur
              1):S68-S73.                                         Heart J,2021,42(5):373-498.
          [ 2 ]  国家卫生健康委,教育部,财政部,等. 关于加强医疗机                  [14]  KEARON  C,AKL  E A,ORNELAS  J,et  al. Antithrom‐
              构药事管理 促进合理用药的意见[EB/OL]. [2022-12-                   botic therapy for VTE disease:chest guideline and expert
              11]. http://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d-  panel report[J]. Chest,2016,149(2):315-352.
              1ac094c47a1fc39cf00f3960e.shtml.               [15]  中国医师协会心血管内科医师分会血栓防治专业委员
          [ 3 ]  CHAN F W H,WONG R S M,LAU W H,et al. Manage‐     会,中华医学会心血管病学分会冠心病与动脉粥样硬化
              ment of Chinese patients on warfarin therapy in two models   学组,中华心血管病杂志编辑委员会. 急性冠状动脉综
              of anticoagulation service: a prospective randomized trial  合征非血运重建患者抗血小板治疗中国专家共识:2018
              [J]. Br J Clin Pharmacol,2006,62(5):601-609.        [J]. 中华心血管病杂志,2019,47(6):430-442.
          [ 4 ]  DAGER W E,BRANCH J M,KING J H,et al. Optimiza‐  [16]  JANION-SADOWSKA A,PAPUGA-SZELA E,ŁUKASZUK
              tion of inpatient warfarin therapy:impact of daily consul‐  R,et al. Non-vitamin K antagonist oral anticoagulants in
              tation  by  a  pharmacist-managed  anticoagulation  service  patients with atrial fibrillation and thrombocytopenia[J]. J
              [J]. Ann Pharmacother,2000,34(5):567-572.           Cardiovasc Pharmacol,2018,72(3):153-160.
          [ 5 ]  DANIELS P R,MANNING D M,MORIARTY J P,et al.   [17]  KIVINIEMI  T,KARJALAINEN  P,RUBBOLI A,et  al.
              Improving  inpatient  warfarin  therapy  safety  using  a   Thrombocytopenia  in  patients  with  atrial  fibrillation  on
              pharmacist-managed protocol[J]. BMJ Open Qual,2018,7  oral  anticoagulation  undergoing  percutaneous  coronary
              (2):e000290.                                        intervention[J]. Am J Cardiol,2013,112(4):493-498.
          [ 6 ]  LIP G Y H,BANERJEE A,BORIANI G,et al. Antithrom‐  [18]  LIVNEH N,BRAEKEN D,DROZDINSKY G,et al. Anti‐
              botic  therapy  for  atrial  fibrillation:chest  guideline  and     coagulation in patients with atrial fibrillation,thrombocy‐
              expert panel report[J]. Chest,2018,154(5):1121-1201.  topenia  and  hematological  malignancy[J].  J  Thromb
          [ 7 ]  LEE  E  J,LEE  A  I.  Thrombocytopenia[J].  Prim  Care,  Thrombolysis,2021,52(2):590-596.
              2016,43(4):543-557.                            [19]  陈智勇,闫小响. 替罗非班引起的血小板减少症相关分
          [ 8 ]  STASI  R,AMADORI  S,OSBORN  J,et  al.  Long-term   析[J]. 中国动脉硬化杂志,2022,30(7):633-639.
              outcome  of  otherwise  healthy  individuals  with  inciden‐  [20]  邹玉彬,谢建新,路磊,等. 多发伤预防性抗凝致肝素诱
              tally  discovered  borderline  thrombocytopenia[J].  PLoS   导 血 小 板 减 少 症 1 例 [J].  临 床 骨 科 杂 志 ,2022,25
              Med,2006,3(3):e24.                                 (2):241.
          [ 9 ]  NEUNERT C,LIM W,CROWTHER M,et al. The American   [21]  闫姝洁,李景文,杨静,等. 比伐卢定用于肝素诱导血小
              Society  of  Hematology  2011  evidence-based  practice   板减少症的体外循环心脏手术患者1例报告[J]. 中国体
              guideline for immune thrombocytopenia[J]. Blood,2011,  外循环杂志,2022,20(1):35-37.
              117(16):4190-4207.                             [22]  刘宏明,王建,丁政. 达肝素钠引起血小板减少合并动脉
          [10]  LU S S,SHE M H,ZENG Q,et al. Sphingosine 1-pho-   血栓形成[J]. 药物不良反应杂志,2022,24(1):44-46.
              sphate and its receptors in ischemia[J]. Clin Chim Acta,  [23]  高小东,李奭慧,商子傲,等. 妊娠合并肺栓塞及血小板
              2021,521:25-33.                                     减少1例[J]. 中华心血管病杂志,2022,50(1):68-71.
          [11]  CHEN P H,CHEN X Y,HE X L. Platelet-derived growth   [24]  康世威,孙佳伟,宫小薇,等. 以肺血栓栓塞症为首发表
              factors  and  their  receptors:structural  and  functional  per‐  现的再生障碍性贫血诊断及治疗策略一例报道[J]. 实用
              spectives[J].  Biochim  Biophys  Acta,2013,1834(10):  心脑肺血管病杂志,2022,30(1):128-131.
              2176-2186.                                     [25]  蔡春花,林少娜,蔡秀梅,等. 肝癌术后弥散性血管内凝
          [12]  COLLET J P,THIELE H,BARBATO E,et al. 2020 ESC     血患者的抗凝治疗1例[J]. 汕头大学医学院学报,2022,
              Guidelines  for  the  management  of  acute  coronary  syn‐  35(1):50-51,55.
              dromes  in  patients  presenting  without  persistent  ST-  [26]  谢雯丽,王莉莉,曲鹏,等. 血小板减少症伴发急性下壁
              segment  elevation[J].  Eur  Heart  J,2021,42(14):1289-  心肌梗死并文献复习 1 例[J]. 中国临床研究,2022,35
              1367.                                              (4):546-548,551.
          [13]  HINDRICKS  G,POTPARA  T,DAGRES  N,et  al.  2020   [27]  陈文浩,张妍,夏书月,等. 急性肺血栓栓塞症合并血小
              ESC  Guidelines  for  the  diagnosis  and  management  of   板减少1例[J]. 沈阳医学院学报,2022,24(2):157-160.
              atrial  fibrillation  developed  in  collaboration  with  the        (收稿日期:2022-06-28  修回日期:2022-12-20)
              European Association for Cardio-Thoracic Surgery(EACTS):                            (编辑:陈 宏)




          中国药房  2023年第34卷第2期                                                 China Pharmacy  2023 Vol. 34  No. 2    · 227 ·
   104   105   106   107   108   109   110   111   112   113   114